[Comparison of therapeutic effect of 2 application forms of a combination of N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium-chloride and sulfanilamidopyrimidine. A widespread mutual test].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000996:Antitussive Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004304:Dosage Forms; D004646:Emphysema / Q000188:drug therapy*; D005100:Expectorants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007251:Influenza, Human / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013411:Sulfadiazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use; D013607:Tablets
D000900:Anti-Bacterial Agents; D000996:Antitussive Agents; D004304:Dosage Forms; D005100:Expectorants; D013449:Sulfonamides; D013607:Tablets; D013411:Sulfadiazine
Vergleich des therapeutischen Effektes zweier Applikationsformen einer Kombination von N-Cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium-chlorid und 2-Sulfanilamidopyrimidine. Eine weitgestreute Gemeinschaftsprüfung.